A. Martinez-vea et al., Echocardiographic evaluation in patients with autosomal dominant polycystic kidney disease and end-stage renal disease, AM J KIDNEY, 34(2), 1999, pp. 264-272
Cardiovascular abnormalities have been considered important extrarenal mani
festations of autosomal dominant polycystic kidney disease (ADPKD). However
, little is known about their prevalence in patients with ADPKD undergoing
hemodialysis (HD). To investigate whether cardiac abnormalities are more pr
evalent in these patients, clinical and echocardiographic manifestations of
cardiovascular disease were evaluated in a group of 32 patients with ADPKD
and a matched control group of 32 patients without diabetes treated by chr
onic HD for more than 6 months. Predialysis systolic and diastolic blood pr
essure (BP), prevalence of hypertension, and number of patients requiring a
ntihypertensive medications were lower in the ADPKD group than controls. Th
ere was no difference in the prevalence of cardiac events, including cardia
c failure, ischemic heart disease, and arrhythmia. Systolic dysfunction, di
astolic patterns, and left ventricular hypertrophy were similar in the two
groups. In patients with ADPKD, simple regression analysis showed left vent
ricular mass (LVM) index was correlated with hemoglobin level and predialyt
ic systolic and diastolic BPs. In multiple regression analysis, predialysis
systolic BP was the only independent variable linked to LVM index. The pre
valence of aortic, mitral, and tricuspid valve disease did not differ betwe
en groups. In conclusion, the occurrence of cardiovascular complications in
patients with ADPKD is similar to that of HD patients with other primary r
enal diseases, although hypertension is less prevalent. (C) 1999 by the Nat
ional Kidney Foundation, Inc.